When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OYST - Oyster Point Pharma under pressure on uneven results from dry eye study
Oyster Point Pharma Inc.
Thinly traded Oyster Point Pharma (OYST-8.7%) is down on 30% higher volume, a modest 99K shares, in reaction to topline results from a Phase 3 clinical trial, ONSET-2, evaluating lead candidate OC-01 (verenicline) nasal spray in patients with mild, moderate and severe dry eye disease.
More news on: Oyster Point Pharma, Inc., Healthcare stocks news, Stocks on the move,